Mizuho Maintains Outperform on HCA Healthcare, Lowers Price Target to $475
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.
Mizuho analyst Ann Hynes maintains HCA Healthcare (NYSE:HCA) with a Outperform and lowers the price target from $525 to $475.